
Sign up to save your podcasts
Or


What if your “normal” thyroid labs are anything but normal—and the symptoms you’re told to ignore are actually warning signs to act now?
In this solo episode of Modern Thyroid and Wellness, host McCall McPherson delivers a passionate and research-backed message on the overlooked dangers of subclinical hypothyroidism. Often labeled as “mild” due to its definition—elevated TSH with normal T4—this condition is far from benign for many patients. McCall dives into the flaws in conventional guidelines that delay treatment until symptoms worsen or labs change, ignoring the lived experience of countless individuals.
Drawing on both clinical expertise and personal insights, McCall outlines the potential consequences of under-treatment, including mental health decline, metabolic issues, and autoimmune progression. She makes a compelling case for earlier, personalized intervention and combination therapies that include T3—not just the standard levothyroxine. This episode is a call to action for patients and providers alike to rethink what subclinical really means, and to prioritize outcomes over outdated lab thresholds.
🔑 Key Topics CoveredIf this episode resonated with you or someone you care about, please share it. Subscribe to Modern Thyroid and Wellness on your favorite podcast app and leave a review to help others discover this critical information.
📲 Follow McCall McPherson & Modern Thyroid and Wellness💻 Website: modernthyroidclinic.com
🐦 X / Twitter: @thyroidexpert
🌐 Host Website: mccallmcpherson.com
📺 YouTube: McCall McPherson Channel
📘 Facebook: McCall McPherson PAC
📸 Instagram: @mccallmcphersonpa
By McCall McPherson, PA-C5
246246 ratings
What if your “normal” thyroid labs are anything but normal—and the symptoms you’re told to ignore are actually warning signs to act now?
In this solo episode of Modern Thyroid and Wellness, host McCall McPherson delivers a passionate and research-backed message on the overlooked dangers of subclinical hypothyroidism. Often labeled as “mild” due to its definition—elevated TSH with normal T4—this condition is far from benign for many patients. McCall dives into the flaws in conventional guidelines that delay treatment until symptoms worsen or labs change, ignoring the lived experience of countless individuals.
Drawing on both clinical expertise and personal insights, McCall outlines the potential consequences of under-treatment, including mental health decline, metabolic issues, and autoimmune progression. She makes a compelling case for earlier, personalized intervention and combination therapies that include T3—not just the standard levothyroxine. This episode is a call to action for patients and providers alike to rethink what subclinical really means, and to prioritize outcomes over outdated lab thresholds.
🔑 Key Topics CoveredIf this episode resonated with you or someone you care about, please share it. Subscribe to Modern Thyroid and Wellness on your favorite podcast app and leave a review to help others discover this critical information.
📲 Follow McCall McPherson & Modern Thyroid and Wellness💻 Website: modernthyroidclinic.com
🐦 X / Twitter: @thyroidexpert
🌐 Host Website: mccallmcpherson.com
📺 YouTube: McCall McPherson Channel
📘 Facebook: McCall McPherson PAC
📸 Instagram: @mccallmcphersonpa

3,955 Listeners

1,111 Listeners

1,004 Listeners

9,268 Listeners

634 Listeners

336 Listeners

154 Listeners

612 Listeners

1,091 Listeners

518 Listeners

1,659 Listeners

566 Listeners

120 Listeners

55 Listeners

61 Listeners